Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 52, Issue 1, Pages 149-160
Publisher
Wiley
Online
2021-10-26
DOI
10.1002/eji.202149619
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Academic labs supporting COVID‐19 diagnostics
- (2021) Marc Veldhoen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies
- (2021) Kayoko Shioda et al. EPIDEMIOLOGY
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Controlling the pandemic during the SARS-CoV-2 vaccination rollout
- (2021) João Viana et al. Nature Communications
- SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe Islands
- (2021) Maria Skaalum Petersen et al. Open Forum Infectious Diseases
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset
- (2020) Bin Lou et al. EUROPEAN RESPIRATORY JOURNAL
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- SARS-CoV-2 (COVID-19) by the numbers
- (2020) Yinon M Bar-On et al. eLife
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
- (2020) Silvia Stringhini et al. LANCET
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
- (2020) Marina Pollán et al. LANCET
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to six months post disease onset
- (2020) Patrícia Figueiredo‐Campos et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low Prevalence Communities and Reveal Durable Humoral Immunity.
- (2020) Tyler J. Ripperger et al. IMMUNITY
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
- (2020) Mark Ainsworth et al. LANCET INFECTIOUS DISEASES
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
- (2020) Anita S. Iyer et al. Science Immunology
- Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study
- (2020) Roberto Pastor-Barriuso et al. BMJ-British Medical Journal
- Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients
- (2011) Lifeng Liu et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search